Softgel Stability Mistakes That Kill Launches
Oxidation, leaking shells, and bloom are not bad luck — they are briefing and process failures. How to brief softgel projects so they survive.

Oxidation, leaking shells, and bloom are not bad luck — they are briefing and process failures. How to brief softgel projects so they survive.

Softgels look simple: oil in a shell. In practice they are one of the most stability-sensitive formats in dietary supplements — especially for omega oils, botanicals, and moisture-sensitive fills.
Unsaturated oils oxidise when oxygen, heat, and light stack up. If your brief never specifies antioxidant strategy, packaging barrier, or nitrogen flush expectations, the first production lot can taste "off" months before expiry.
Gelatin and HPMC shells behave differently with humidity. Skipping controlled drying or packing warm softgels into bottles creates welded clusters and leakers — both expensive returns.
Temperature cycling in shipping creates white bloom that consumers read as "expired." Stability protocols must include distribution-like conditions, not only static lab shelves.
Most softgel stability problems are decided before the first shell is formed. The fill chemistry, the antioxidant package, and the shell material together set the ceiling on shelf life — no amount of downstream drying or packaging can rescue a formula that was always going to oxidise.
For omega oils specifically, oxidation is the dominant failure mode. Polyunsaturated oils react with oxygen, and the reaction accelerates with heat and light. A credible brief specifies the peroxide value target at fill, the tocopherol or rosemary extract used as a carrier antioxidant, and whether the line runs a nitrogen flush to displace headspace oxygen. If none of that is in the brief, the manufacturer is making assumptions — and the first lot is the experiment.
Shell choice matters more than founders expect. Gelatin shells are the default and well-understood, but they are hygroscopic — they absorb moisture and become brittle in dry climates, sticky in humid ones. Vegetarian (HPMC) shells behave differently and can suit certain fills better, but they have their own sealing and drying profile. Enteric coatings add another layer: they resist stomach acid for targeted release, but they also add a coating step that has its own stability and adhesion tests.
A softgel that is stable in the lab can still fail in distribution. The bottle, the cap liner, the desiccant, and even the fill volume of the bottle all change how the product ages on a real shelf.
A generic potency panel does not catch softgel-specific risks. Ask for:
Stability data is only useful if you know what it can and cannot predict. Softgel programs typically run two conditions in parallel, and founders should understand the difference rather than accept a single number.
Accelerated stability (40°C / 75% RH for 6 months) is the fast forecast. It is good for an early read on whether a formula is viable, but it over-predicts failure for heat-sensitive actives — a softgel that "fails" accelerated at month three may be perfectly stable at room temperature for two years. Treat accelerated as a screening tool, not a verdict.
Real-time stability (25°C / 60% RH, measured over 12–24 months) is the number that actually goes on the label. It is slower and more expensive, but it is the only data that defends your expiry date against a retailer review or an Amazon compliance request. A manufacturer offering only accelerated data is giving you a projection, not a measurement.
The softgel-specific trap: neither condition fully models distribution. A bottle that sits in a hot shipping container or a warehouse cycling between day and night temperatures ages differently than one on a static lab shelf. Temperature-cycling studies — where the product is moved between conditions to simulate real logistics — catch the bloom and shell-stress failures that static chambers miss. For any softgel that will ship through extreme climates, ask whether the protocol includes distribution-like cycling, not just the two standard conditions.
Softgel stability failures are expensive precisely because they surface late. A potency shortfall found at release is a re-test. An oxidation problem found after the product ships is a recall — and softgel recalls are among the costliest in the category, because the failure (rancidity, leaking, bloom) is visible to the consumer, not just to a lab.
The pattern is the same as every other compliance question in supplements: the cost of asking for the right protocol goes up the later you ask. Asking at the brief costs an email. Asking after the first production run costs a re-validation. Asking after launch costs the SKU.
At HiGO, softgel programs typically start at 300,000–500,000 units as capacity scales. We would rather sequence your timeline honestly than rush a shell that fails in the field.
If softgels are your hero SKU: book a technical call early — shell and fill decisions lock most of your timeline.
Our Author

Manufacturing Operations Editor
Daniel focuses on production transfer, equipment fit, process controls, scale-up, packaging operations, and the scheduling decisions that move a supplement from approval to finished goods.
Tell us about your project — format, volume, timeline — and get a tailored quote within 24 hours.
Get a QuoteFDA-registered, cGMP-certified and SQF-registered production in Ontario, California - documentation packs ready for your retail and marketplace onboarding.
FDA Registered Facility
cGMP Certified Facility
HACCP / GMP Certified
Non-GMO
Made in USA
SQF RegisteredGet a tailored manufacturing quote within 24 hours — format, volume, and timeline.
Get a Quote